New injection aims to ease lung pressure in scarred lungs
Disease control
Not yet recruiting
This phase 2 trial tests an injected drug called TX000045 in 25 people who have high blood pressure in the lungs due to scarring lung disease. The main goal is to see if the drug lowers lung blood pressure and is safe over 16 weeks. Researchers will also check for side effects an…
Phase: PHASE2 • Sponsor: Tectonic Operating Company, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC